| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Former Director | Director
1 company
Constance J. Hallquist last filed a Form 4 in October 2023, as Former Director at MED. Constance J. Hallquist's net worth is not public. Form 4 filings only show shares in the companies where this person was an insider, as of the last filing.
Our model assigns Constance J. Hallquist a middling insider score of 59/100, based on 5 past trades. Over a 12-month horizon, 40.0% of those trades were profitable, with an average 12-month return of -11.0%.
At the last filing, the largest reported position was 2,152 shares of MED. The MED filings lean toward selling, a net 13,842 shares.
Constance J. Hallquist has 19 Form 4 filings on record from September 2015 to October 2023, all as Former Director at Medifast (MED), 2015–2023.
The 23 reported transactions were 10 stock awards, 6 open-market sales, 3 open-market purchases and 2 option exercises, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 3 purchases worth about $3K and 6 sales worth about $2.2M.
The largest open-market purchase was 13 shares of MED at an average $87.50 on May 9, 2023, about $1K. Twelve months later MED was down 71%.
The largest open-market sale was 4,500 shares of MED at an average $259.02 on March 3, 2021, about $1.2M.
Shares as reported in the last Form 4 for each company; the most recent is from October 2023. Values use today's prices. Any trades after the last filing were not reported, so current holdings may differ.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Oct 6, 2023 | MED Medifast Inc | Former Director | Sell | 5,613 | $73.87 | $414,632.31 | -72.3% | -12.0% | -75.0% | |
| May 9, 2023 | MED Medifast Inc | Director | Buy | 13 | $87.50 | $1,167.43 | +0.2% | +9.8% | -71.5% | |
| Feb 7, 2023 | MED Medifast Inc | Director | Buy | 10 | $114.97 | $1,143.95 | +0.1% | -22.0% | -53.0% | |
| Nov 8, 2022 | MED Medifast Inc | Director | Buy | 11 | $106.93 | $1,126.72 | +0.1% | +3.9% | -38.9% | |
| Jul 2, 2021 | MED Medifast Inc | Director | Sell | 542 | $285.09 | $154,518.78 | -7.8% | -32.2% | -33.5% | |
| Mar 3, 2021 | MED Medifast Inc | Director | Sale+OE | 4,500 | $259.02 | $1,165,590.00 | -41.6% | - | - | |
| Jul 2, 2020 | MED Medifast Inc | Director | Sell | 535 | $149.25 | $79,848.75 | -7.8% | - | - | |
| Dec 3, 2018 | MED Medifast Inc | Director | Sell | 1,343 | $153.84 | $206,607.12 | -22.3% | - | - | |
| Nov 9, 2018 | MED Medifast Inc | Director | Sell | 1,343 | $160.12 | $215,041.16 | -18.2% | - | - |